A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma

NCT01412307 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

36

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Adult Hodgkin Lymphoma

Interventions

DRUG: Lenalidomide
DRUG: Bendamustine
OTHER: Bio-specimen Retention

Sponsor

Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale